MSC therapy — a regenerative approach to tissue and joints

• Outpatient
• Intravenous or targeted to the area
• Your own or cord-derived cells
• Course — per the physician's plan

• Studied for decades

  Mesenchymal stem cells (MSCs) have been described and actively studied since the late 1990s; their regenerative potential is a subject of global science.

• GMP-standard preparation

  Isolation, culture and cell control follow GMP protocols, with multi-stage quality checks.

• Used by indication

  In the cluster the field is considered on strict indications — for regenerative and recovery goals, by the physician's decision.

• Active and not slowing down

  Sport, training, an active life — and a joint or your back increasingly limits what you're used to allowing yourself.

• Tired of the painkiller loop

  You want to address the cause of pain, not mute it with pills for years.

• Before deciding on surgery

  You want to consider a regenerative route before agreeing to surgery — as assessed by a physician.

• After injuries and overload

  Old injuries, tendinopathies and slow tissue healing get in the way of living fully.

• Thinking years ahead

  You want to support joints and tissue early, before a small problem becomes a large one.

• Joints and spine: osteoarthritis, osteochondrosis, pain in knees, shoulders and back
• Sports injuries and overload
• Ligaments and tendons: chronic inflammation, tendinopathies
• Vessels and microcirculation: diabetic and ischaemic disturbances
• Skin and soft tissue: reduced elasticity, slow healing
• Neurological support — by indication

From approx. ¥36,000 per intra-articular injection (≈ $5,000) and from ¥50,000 per systemic infusion (≈ $6,950) — the zone's registered prices; the hospital quotes the course

The exact cost is determined only after diagnostics — the programme is tailored individually, by indication. Payment is made directly to the cluster's clinic, by official invoice. For context: cells into the knee here cost ¥36,000 (≈ $5,000) per injection at the zone's registered price, against $35,000–50,000 in Western European clinics; a systemic infusion here is from ¥50,000 (≈ $6,950), against $20,000–22,000 in Japan and Switzerland. All prices → · Zone registry → · Country comparison →

1. 1
   Diagnostics

   Tests and, if needed, ultrasound or MRI.

2. 2
   Material collection

   Blood, adipose tissue or bone marrow under sterile conditions.

3. 3
   Isolation and activation

   By a standardised protocol (GMP / ISO).

4. 4
   Culture

   10–14 days to the target cell dose.

5. 5
   Administration

   Intravenously and/or locally (joint, ligament, tissue).

6. 6
   Follow-up

   Check-up in 2–4 weeks.

A course is usually 1–2 procedures, 2–4 weeks apart, outpatient. The work is done with multi-stage laboratory control. The physician assesses dynamics; the result is individual and not guaranteed.

• Low immunogenicity

  These are immature “all-purpose” cells (multipotent) the immune system barely recognises, so the risk of rejection is minimal.

• GMP quality control

  Every cell batch is tested for bacteria, fungi, mycoplasma, endotoxins, viability, purity and uniformity.

• Tolerability

  By accumulated clinical experience, the most common reaction is a brief temperature rise on the procedure day, usually self-resolving. Individual tolerability is assessed by the physician.

• When it isn't performed

  Contraindications usually considered include active infection, uncontrolled oncological processes, pregnancy and others. The physician decides after diagnostics.